TTALO.HE
Terveystalo Oyj [TTALO.HE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TTALO.HE Stock Summary
Top 10 Correlated ETFs
TTALO.HE
Top 10 Correlated Stocks
TTALO.HE
In the News
TTALO.HE Financial details
Company Rating
Neutral
Market Cap
960.57M
Income
-42.2M
Revenue
1.29B
Book val./share
4.07
Cash/share
0.3
Dividend
0.28
Dividend %
3.53%
Employees
9.82K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
34.02
Forward P/E
-
PEG
-1.23
P/S
0.78
P/B
1.74
P/C
26.3
P/FCF
7.97
Quick Ratio
0.11
Current Ratio
0.57
Debt / Equity
0.9
LT Debt / Equity
0.77
-
-
EPS (TTM)
-0.34
EPS next Y
-
EPS next Q
-
EPS this Y
-273.68%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
4.53%
Revenue Q/Q
22.07%
EPS Q/Q
-2054.02%
-
-
-
-
SMA20
14.29%
SMA50
-
SMA100
14.29%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
5%
ROC
0.05%
Gross Margin
58%
Oper. Margin
4%
Profit Margin
2%
Payout
120%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
6.48-8.57
52W High
-1.38%
52W Low
+31.5%
RSI
60
Rel Volume
0.52
Avg Volume
43.96K
Volume
22.83K
Perf Week
4.37%
Perf Month
10.2%
Perf Quarter
5.34%
Perf Half Y
4.64%
-
-
-
-
Beta
0.698
-
-
Volatility
0.19%, 0.27%
Prev Close
-0.75%
Price
7.89
Change
-2.71%
TTALO.HE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 8.1 | 7.75 | 9.08 | 9.95 | 10.16 | |
| Net income per share | 0.42 | 0.36 | 0.63 | 0.19 | -0.33 | |
| Operating cash flow per share | 1.36 | 1.13 | 1.53 | 1.11 | 1.09 | |
| Free cash flow per share | 1.1 | 0.87 | 1.2 | 0.65 | 0.77 | |
| Cash per share | 0.31 | 0.6 | 0.29 | 0.31 | 0.3 | |
| Book value per share | 4.25 | 4.49 | 4.79 | 4.68 | 4.07 | |
| Tangible book value per share | -3.14 | -2.85 | -3.26 | -3.42 | -3.22 | |
| Share holders equity per share | 4.25 | 4.49 | 4.79 | 4.68 | 4.07 | |
| Interest debt per share | 4.72 | 4.54 | 4.46 | 4.88 | 3.86 | |
| Market cap | 1.42B | 1.28B | 1.51B | 790.68M | 1B | |
| Enterprise value | 1.97B | 1.77B | 2.03B | 1.36B | 1.6B | |
| P/E ratio | 26.31 | 27.91 | 18.71 | 32.4 | -23.75 | |
| Price to sales ratio | 1.38 | 1.3 | 1.3 | 0.63 | 0.78 | |
| POCF ratio | 8.2 | 8.89 | 7.71 | 5.61 | 7.26 | |
| PFCF ratio | 10.17 | 11.56 | 9.9 | 9.68 | 10.32 | |
| P/B Ratio | 2.63 | 2.24 | 2.47 | 1.34 | 1.94 | |
| PTB ratio | 2.63 | 2.24 | 2.47 | 1.34 | 1.94 | |
| EV to sales | 1.91 | 1.79 | 1.75 | 1.08 | 1.24 | |
| Enterprise value over EBITDA | 11.59 | 11.22 | 9.9 | 6.73 | 9.14 | |
| EV to operating cash flow | 11.36 | 12.31 | 10.37 | 9.63 | 11.59 | |
| EV to free cash flow | 14.08 | 15.99 | 13.31 | 16.62 | 16.48 | |
| Earnings yield | 0.04 | 0.04 | 0.05 | 0.03 | -0.04 | |
| Free cash flow yield | 0.1 | 0.09 | 0.1 | 0.1 | 0.1 | |
| Debt to equity | 1.09 | 0.99 | 0.92 | 1.03 | 0.9 | |
| Debt to assets | 0.43 | 0.42 | 0.38 | 0.41 | 0.33 | |
| Net debt to EBITDA | 3.22 | 3.11 | 2.54 | 2.81 | 3.42 | |
| Current ratio | 0.56 | 0.6 | 0.44 | 0.62 | 0.64 | |
| Interest coverage | 6.56 | 6.65 | 11.71 | 6.82 | 2.67 | |
| Income quality | 2.6 | 2.54 | 1.94 | 4.56 | -3.27 | |
| Dividend Yield | 0 | 0.01 | 0.02 | 0.04 | 0.04 | |
| Payout ratio | 0 | 0.36 | 0.41 | 1.45 | -0.84 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0.09 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.69 | 0.69 | 0.71 | 0.69 | 0.65 | |
| Capex to operating cash flow | -0.19 | -0.23 | -0.22 | -0.42 | -0.3 | |
| Capex to revenue | -0.03 | -0.03 | -0.04 | -0.05 | -0.03 | |
| Capex to depreciation | -0.37 | -0.36 | -0.47 | -0.44 | -0.38 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 6.38 | 6.03 | 8.26 | 4.51 | 5.53 | |
| ROIC | 0.05 | 0.04 | 0.06 | 0.04 | 0.06 | |
| Return on tangible assets | 0.13 | 0.11 | 0.19 | 0.05 | -0.09 | |
| Graham Net | -5.5 | -5.02 | -5.57 | -5.83 | -5.94 | |
| Working capital | -117.2M | -121.7M | -219.2M | -117.2M | -107.7M | |
| Tangible asset value | -399.9M | -362.3M | -414.9M | -432.6M | -407.8M | |
| Net current asset value | -670.3M | -610.5M | -666.9M | -697.7M | -711.4M | |
| Invested capital | 1.09 | 0.99 | 0.92 | 1.03 | 0.9 | |
| Average receivables | 91.3M | 98.35M | 107.75M | 131.6M | 145.35M | |
| Average payables | 35.85M | 39.3M | 48.6M | 53.05M | 136.85M | |
| Average inventory | 5.7M | 6.2M | 6.6M | 6.5M | 6.85M | |
| Days sales outstanding | 35.98 | 35.19 | 38.06 | 41.4 | 41.96 | |
| Days payables outstanding | 29.72 | 32.7 | 42.64 | 34.02 | 75.22 | |
| Days of inventory on hand | 4.32 | 5.55 | 4.78 | 4.58 | 2.38 | |
| Receivables turnover | 10.14 | 10.37 | 9.59 | 8.82 | 8.7 | |
| Payables turnover | 12.28 | 11.16 | 8.56 | 10.73 | 4.85 | |
| Inventory turnover | 84.45 | 65.82 | 76.38 | 79.65 | 153.58 | |
| ROE | 0.1 | 0.08 | 0.13 | 0.04 | -0.08 | |
| Capex per share | -0.26 | -0.26 | -0.34 | -0.47 | -0.32 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.65 | 2.7 | 2.55 | 2.22 | 2.71 | |
| Net income per share | 0.06 | 0.09 | 0.06 | 0.03 | -0.51 | |
| Operating cash flow per share | 0.6 | 0.28 | 0.2 | 0.28 | 0.43 | |
| Free cash flow per share | 0.46 | 0.21 | 0.12 | 0.21 | 0.34 | |
| Cash per share | 0.31 | 0.34 | 0.09 | 0.28 | 0.3 | |
| Book value per share | 4.68 | 4.48 | 4.52 | 4.56 | 4.07 | |
| Tangible book value per share | -3.42 | -3.58 | -3.48 | -3.41 | -3.22 | |
| Share holders equity per share | 4.68 | 4.48 | 4.52 | 4.56 | 4.07 | |
| Interest debt per share | 4.82 | 4.99 | 4.89 | 5.05 | 3.72 | |
| Market cap | 790.93M | 888.39M | 1.05B | 956.76M | 1B | |
| Enterprise value | 1.36B | 1.47B | 1.65B | 1.55B | 1.6B | |
| P/E ratio | 26.02 | 20.01 | 34.85 | 72.48 | -3.91 | |
| Price to sales ratio | 2.36 | 2.6 | 3.24 | 3.41 | 2.93 | |
| POCF ratio | 10.34 | 24.75 | 40.36 | 26.88 | 18.56 | |
| PFCF ratio | 13.64 | 33.15 | 69.23 | 36.8 | 23.58 | |
| P/B Ratio | 1.34 | 1.57 | 1.83 | 1.66 | 1.94 | |
| PTB ratio | 1.34 | 1.57 | 1.83 | 1.66 | 1.94 | |
| EV to sales | 4.06 | 4.32 | 5.11 | 5.54 | 4.67 | |
| Enterprise value over EBITDA | 32.02 | 31.94 | 37.43 | 41.88 | 31.08 | |
| EV to operating cash flow | 17.75 | 41.02 | 63.59 | 43.65 | 29.64 | |
| EV to free cash flow | 23.41 | 54.94 | 109.08 | 59.76 | 37.66 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0 | -0.06 | |
| Free cash flow yield | 0.07 | 0.03 | 0.01 | 0.03 | 0.04 | |
| Debt to equity | 1.03 | 1.11 | 1.07 | 1.1 | 0.9 | |
| Debt to assets | 0.41 | 0.42 | 0.42 | 0.43 | 0.33 | |
| Net debt to EBITDA | 13.37 | 12.67 | 13.68 | 16.09 | 11.61 | |
| Current ratio | 0.62 | 0.58 | 0.54 | 0.57 | 0.64 | |
| Interest coverage | 4 | 3.67 | 2.73 | 1.5 | -7.61 | |
| Income quality | 7.81 | 2.55 | 2.64 | 9.89 | -0.84 | |
| Dividend Yield | 0.02 | 0.02 | 0 | 0 | 0.02 | |
| Payout ratio | 2.33 | 1.5 | 0.15 | 0 | -0.28 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0.09 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.69 | 0.68 | 0.69 | 0.68 | 0.65 | |
| Capex to operating cash flow | -0.24 | -0.25 | -0.42 | -0.27 | -0.21 | |
| Capex to revenue | -0.06 | -0.03 | -0.03 | -0.03 | -0.03 | |
| Capex to depreciation | -0.63 | -0.34 | -0.38 | -0.36 | -0.1 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.51 | 2.97 | 2.45 | 1.64 | 6.81 | |
| ROIC | 0.01 | 0.01 | 0.01 | 0.01 | -0.05 | |
| Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.01 | -0.13 | |
| Graham Net | -5.96 | -6.09 | -6.06 | -6.01 | -5.94 | |
| Working capital | -117.2M | -151.9M | -145.6M | -139.9M | -107.7M | |
| Tangible asset value | -432.6M | -452.7M | -439.9M | -431.8M | -407.8M | |
| Net current asset value | -697.7M | -728.4M | -725.1M | -721.1M | -711.4M | |
| Invested capital | 1.03 | 1.11 | 1.07 | 1.1 | 0.9 | |
| Average receivables | 136M | 138.45M | 155.5M | 147.9M | 144.8M | |
| Average payables | 122.35M | 141.7M | 226.35M | 214.1M | 217.3M | |
| Average inventory | 7.1M | 6.65M | 6.75M | 6.9M | 7.05M | |
| Days sales outstanding | 32.26 | 41.4 | 43.02 | 45.47 | 38.88 | |
| Days payables outstanding | 31.32 | 148.25 | 145.64 | 162.29 | 54.48 | |
| Days of inventory on hand | 4.22 | 4.24 | 4.54 | 5.41 | 1.72 | |
| Receivables turnover | 2.79 | 2.17 | 2.09 | 1.98 | 2.32 | |
| Payables turnover | 2.87 | 0.61 | 0.62 | 0.55 | 1.65 | |
| Inventory turnover | 21.33 | 21.24 | 19.84 | 16.63 | 52.28 | |
| ROE | 0.01 | 0.02 | 0.01 | 0.01 | -0.12 | |
| Capex per share | -0.15 | -0.07 | -0.09 | -0.08 | -0.09 |
TTALO.HE Frequently Asked Questions
What is Terveystalo Oyj stock symbol ?
Terveystalo Oyj is a FI stock and trading under the symbol TTALO.HE
What is Terveystalo Oyj stock quote today ?
Terveystalo Oyj stock price is $7.89 today.
Is Terveystalo Oyj stock public?
Yes, Terveystalo Oyj is a publicly traded company.
Company Profile
- Volume Average 43.96K
- Market Capitalization 960.57M
- Employee 9.82K
- CEO Mr. Ville Iho
- Headquarters Helsinki,FI
- IPO Date 2017-10-11
-
Website
https://www.terveystalo.com 
Terveystalo Oyj provides occupational healthcare services in Finland. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; and outsourcing services, staffing services, child welfare services, oral health, laboratory, imaging, wellbeing, day surgery, healthcare outsourcing, healthcare staffing, and primary and specialty care services. It also provides a suite of digital healthcare services; and clinical research services. The company serves private individuals, companies and communities, insurance companies, and public sector customers. It operates 360 clinics, which include 18 hospital units and 38 dental clinics; and 73 Rela hierojat massage therapy units. The company was founded in 2001 and is based in Helsinki, Finland.
